Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
KLONOPIN
Generic name / active ingredient
clonazepam
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-09-04

Copy from the pack in hand

Source-linked reading points

  • The 0.5, 1 and 2 mg figures are labelled amounts per tablet, while 100 tablets is the bottle count. Do not add these numbers or calculate today's tablet count from remaining tablets or symptoms.
  • The current label directs swallowing the tablet whole with water. The 0.5 mg score is an exact-product clue, not universal permission to halve it; the current 1 mg and 2 mg products are unscored.
  • Opioids, alcohol, other benzodiazepines, sleep medicines, sedating antihistamines and other CNS depressants may add effects. The label warns that opioid co-use can cause profound sedation, respiratory depression, coma and death; marked somnolence, slowed breathing, altered awareness or inability to wake requires local emergency services.
  • Continued use can produce physical dependence. Abrupt stopping or rapid reduction can cause life-threatening acute withdrawal reactions, including seizures. Tapering must be individualised by a professional and cannot use one-for-one milligram conversion from VALIUM, XANAX or another benzodiazepine.

Reviewed presentation examples — compare every field

  • Clonazepam 0.5 mg per tablet; 100-tablet bottleNDC 61269-605-10
  • Clonazepam 1 mg per tablet; 100-tablet bottleNDC 61269-610-10
  • Clonazepam 2 mg per tablet; 100-tablet bottleNDC 61269-620-10

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-04
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image